Eli Lilly and Company (LLY) Planning New Irish Biopharma Plant
12/15/2011 7:56:39 AM
Eli Lilly has filed a planning application to build a new 23,000 sq. m. biologics facility at its manufacturing site in County Cork, Ireland. The three-story building marks another phase of investment in the biopharmaceutical-producing capacity of the site in Dunderrow, Kinsale, coming after a €400 million project to build a 158,000 sq. m. facility there started in 2008. Construction of the biomanufacturing plant - which specialises in monoclonal antibodies - was completed in 2010 and it is due to come fully online next year.